pancreatic cancer
The test assigns a pancreatic cancer subtype based on the expression of 16 genes measured using an array.
Foundation Medicine, Merus to Develop CDx for Cancer Drug to Treat Patients With NRG1 Fusions
The companies will use Foundation's RNA sequencing platform to develop a companion diagnostic for Merus' bispecific antibody zenocutuzumab.
Biological Dynamics Shutters; Successor Firm to Advance Exosome Platform
The company closed its doors June 30, according to a Worker Adjustment and Retraining Notification filed in California.
The company's PreveCol test uses molecular biomarkers and clinical features to detect colorectal cancer and precancerous lesions from blood samples.
Genialis, PanCAN Partner to Validate Biomarker for KRAS-Inhibitor Response, Benefit
The collaboration will help validate the use of the Genialis KrasID panel to predict outcomes for pancreatic cancer patients who are treated with KRAS inhibitors.
Feb 14, 2024
Oct 11, 2022